References
- Bendik I, Schraml P, Ludwig CU (1998). Characterization of MAST9/Hevin, a SPARC-like protein, that is downregulated in non-small cell lung cancer. Cancer Res, 58, 626-9.
- Claeskens A, Ongenae N, Neefs JM, et al (2000). Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer, 82, 1123-30. https://doi.org/10.1054/bjoc.1999.1051
- Eheman C, Henley SJ, Ballard-Barbash R, et al (2012). Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer, 118, 2338-66. https://doi.org/10.1002/cncr.27514
- Esposito I, Kayed H, Keleg S, et al (2007). Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia, 9, 8-17. https://doi.org/10.1593/neo.06646
- Girard JP, Springer TA (1995). Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity, 2, 113-23. https://doi.org/10.1016/1074-7613(95)90083-7
- Girard JP, Springer TA (1996). Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem, 271, 4511-7. https://doi.org/10.1074/jbc.271.8.4511
- Hambrock HO, Nitsche DP, Hansen U, et al (2003). SC1/hevin. An extracellular calcium-modulated protein that binds collagen I. J Biol Chem, 278, 11351-8. https://doi.org/10.1074/jbc.M212291200
- Hu H, Zhang H, Ge W, et al (2012). Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers. Clin Cancer Res, 18, 5438-48. https://doi.org/10.1158/1078-0432.CCR-12-0124
- Hulvat MC, Hansen NM, Jeruss JS (2009). Multidisciplinary care for patients with breast cancer. Surg Clin North Am, 89, 133-76, ix. https://doi.org/10.1016/j.suc.2008.10.002
- Hurley PJ, Marchionni L, Simons BW, et al (2012). Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proc Natl Acad Sci USA, 109, 14977-82. https://doi.org/10.1073/pnas.1203525109
- Isler SG, Ludwig CU, Chiquet-Ehrismann R, Schenk S (2004). Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors. Int J Oncol, 25, 1073-9.
- Isler SG, Schenk S, Bendik I, et al (2001). Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol, 18, 521-6.
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Kallioniemi OP, Wagner U, Kononen J, Sauter G (2001). Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet, 10, 657-62. https://doi.org/10.1093/hmg/10.7.657
- Kataja V, Castiglione M, ESMO Guidelines Working Group (2008). Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 19, ii11-3. https://doi.org/10.1093/annonc/mdn298
- Kononen J, Bubendorf L, Kallioniemi A, et al (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 4, 844-7. https://doi.org/10.1038/nm0798-844
- Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST (2006). SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol, 210, 459-68. https://doi.org/10.1002/path.2068
- Li P, Qian J, Yu G, et al (2012). Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. J Surg Oncol, 105, 31-7. https://doi.org/10.1002/jso.22025
- Long N, Moore MA, Chen W, et al (2010). Cancer epidemiology and control in north-East Asia - past, present and future. Asian Pac J Cancer Prev, 11 suppl 2, 107-48.
- Mencalha AL, Levinsphul A, Deterling LC, Pizzatti L, Abdelhay E (2008). SPARC-like1 mRNA is overexpressed in human uterine leiomyoma. Mol Med Report, 1, 571-4.
- Nelson PS, Plymate SR, Wang K, et al (1998). Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res, 58, 232-6.
- Rosman DS, Kaklamani V, Pasche B (2007). New insights into breast cancer genetics and impact on patient management. Curr Treat Options Oncol, 8, 61-73. https://doi.org/10.1007/s11864-007-0021-5
- Russo J, Calaf G, Sohi N, et al (1993). Critical steps in breast carcinogenesis. Ann N Y Acad Sci, 698, 1-20. https://doi.org/10.1111/j.1749-6632.1993.tb17187.x
- Shen FR, Liu M, Zhang X, et al (2012). Health-related quality of life among breast cancer patients and its Influencing Factor in a Chinese Population. Asian Pac J Cancer Prev, 13, 3747-50. https://doi.org/10.7314/APJCP.2012.13.8.3747
- St Croix B, Rago C, Velculescu V, et al (2000). Genes expressed in human tumor endothelium. Science, 289, 1197-202. https://doi.org/10.1126/science.289.5482.1197
- Sullivan MM, Sage EH (2004). Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family. Int J Biochem Cell Biol, 36, 991-6. https://doi.org/10.1016/j.biocel.2004.01.017
- Zhang H, Widegren E, Wang DW, Sun XF (2011). SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer. Tumour Biol, 32, 1225-31. https://doi.org/10.1007/s13277-011-0226-x
- Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA (2011). Identification of common differentially expressed genes in urinary bladder cancer. PLoS One, 6, e18135. https://doi.org/10.1371/journal.pone.0018135
Cited by
- Update December 2013 vol.11, pp.4, 2013, https://doi.org/10.1089/lrb.2013.1142
- Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling vol.9, pp.10, 2014, https://doi.org/10.1371/journal.pone.0108818
- SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-4206-4
- Expression of Krüppel-like factor 4 in breast cancer tissues and its effects on the proliferation of breast cancer MDA-MB-231 cells vol.13, pp.5, 2017, https://doi.org/10.3892/etm.2017.4262
- Robust identification of target genes and outliers in triple-negative breast cancer data pp.1477-0334, 2018, https://doi.org/10.1177/0962280218794722
- Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors vol.18, pp.1, 2018, https://doi.org/10.1186/s12876-018-0833-8
- Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma vol.82, pp.1, 2019, https://doi.org/10.1080/15287394.2018.1551645